Fig. 4.
Fig. 4. CD95 and CD95L expression following resveratrol treatment of HL60 cells. (A) HL60 cells were treated with 32 μmol/L resveratrol, and surface expression of CD95 and CD95L was analyzed by flow cytometry at 6 hours, 12 hours, and 24 hours as described in Materials and Methods. The shaded histograms are for mouse IgG1κ used as an isotype control, the dotted lines represent nontreated HL60 cells, and the solid lines indicate resveratrol-treated HL60 cells. At least 10,000 events were counted, and data shown are representative of at least three separate experiments. (B) RT-PCR amplification of CD95L and β-actin mRNA following treatment of HL60 cells with 32 μmol/L resveratrol for 0, 4, 8, and 20 hours.

CD95 and CD95L expression following resveratrol treatment of HL60 cells. (A) HL60 cells were treated with 32 μmol/L resveratrol, and surface expression of CD95 and CD95L was analyzed by flow cytometry at 6 hours, 12 hours, and 24 hours as described in Materials and Methods. The shaded histograms are for mouse IgG1κ used as an isotype control, the dotted lines represent nontreated HL60 cells, and the solid lines indicate resveratrol-treated HL60 cells. At least 10,000 events were counted, and data shown are representative of at least three separate experiments. (B) RT-PCR amplification of CD95L and β-actin mRNA following treatment of HL60 cells with 32 μmol/L resveratrol for 0, 4, 8, and 20 hours.

Close Modal

or Create an Account

Close Modal
Close Modal